INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Brandon Lake Last week Weeks at no. 1 Weeks on chart B.M.Lake, B.W.Hastings, M.Nichols, Z.J.Lawson, S.Furtick M.Nichols Brandon Lake/Essential/PLG Week of February 8, 2025 click to see more ...

Amgen Inc. convinced a judicial panel to centralize four federal lawsuits accusing biosimilar-drug makers of infringing patents for Prolia and Xgeva, its blockbuster bone-strengthening treatments.

We list the best Gantt chart software, to make it simple and easy to better visualize and manage progress when dealing with larges projects. Gantt chart software can be a powerful weapon in a ...

Plus, check out our handy semaglutide weight loss dosage chart for an easy-to-follow overview of what to expect. Semaglutide is the active ingredient in three medications approved by the U.S. Food ...

The prescribed dosage for fluoxetine may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

Drug addiction is a condition in which there is uncontrolled use of a substance with a harmful outcome. Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated ...

In the following chart, we are able to follow the development ... in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered ...

Prolia revenues came in at $1.17 billion ... the fourth quarter compared with $36 million in the third quarter. The drug’s 86% sequential growth was driven by volume growth and favorable ...

Why it matters: Amgen's performance in 2024 was in line with our estimates, but 2025 guidance is ahead of our prior outlook, largely due to biosimilar denosumab competition (bone drug Prolia and ...

Azstarys (serdexmethylphenidate/dexmethylphenidate) is a prescription drug that’s taken to treat ADHD. The drug comes as an oral capsule that you take once per day ...